Literature DB >> 19902270

Effects of GH in human muscle and fat.

Jens Otto Lunde Jørgensen1, Kristine Z Rubeck, Thomas S Nielsen, Berthil F F Clasen, Mikkel Vendelboe, Thomas K Hafstrøm, Michael Madsen, Sten Lund.   

Abstract

Skeletal muscle is the major constituent of lean body mass and a major determinant of energy expenditure both at rest and during physical activity. Growth hormone, in turn, influences muscle mass as well as energy expenditure. Growth hormone substitution in adults increases muscle mass by 5-10%, but part of the effect is attributed to rehydration rather than protein accretion. In addition, GH regulates substrate metabolism in muscle and in particular antagonizes insulin-stimulated glucose disposal. This effect is linked to increased free fatty acid (FFA) flux but the molecular mechanisms remain unclear. During fasting, GH-induced insulin resistance may be favorable by reducing the demand of gluconeogenesis from protein. But in the postprandial phase, GH exposure may compromise glucose tolerance via the same mechanisms. Understanding the mechanisms whereby GH antagonizes insulin-stimulated glucose disposal in muscle is an important future research field with implications for a variety of clinical conditions ranging from malnutrition to obesity and type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19902270     DOI: 10.1007/s00467-009-1334-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  33 in total

1.  GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus.

Authors:  Jens O L Jørgensen; Niels Jessen; Steen B Pedersen; Esben Vestergaard; Lars Gormsen; Sten A Lund; Nils Billestrup
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-06-06       Impact factor: 4.310

2.  Impact of fasting on growth hormone signaling and action in muscle and fat.

Authors:  Louise Moller; Lisa Dalman; Helene Norrelund; Nils Billestrup; Jan Frystyk; Niels Moller; Jens Otto Lunde Jorgensen
Journal:  J Clin Endocrinol Metab       Date:  2008-12-09       Impact factor: 5.958

3.  The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone.

Authors:  Helene Nørrelund; K Sreekumaran Nair; Steen Nielsen; Jan Frystyk; Per Ivarsen; Jens Otto Lunde Jørgensen; Jens Sandahl Christiansen; Niels Møller
Journal:  J Clin Endocrinol Metab       Date:  2003-09       Impact factor: 5.958

4.  Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.

Authors:  J O Jørgensen; N Vahl; T B Hansen; L Thuesen; C Hagen; J S Christiansen
Journal:  Clin Endocrinol (Oxf)       Date:  1996-12       Impact factor: 3.478

5.  Normal growth and development in the absence of hepatic insulin-like growth factor I.

Authors:  S Yakar; J L Liu; B Stannard; A Butler; D Accili; B Sauer; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

6.  Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance.

Authors:  R A Mooney; J Senn; S Cameron; N Inamdar; L M Boivin; Y Shang; R W Furlanetto
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

7.  Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion.

Authors:  Niels Jessen; Christian B Djurhuus; Jens O L Jørgensen; Lasse S Jensen; Niels Møller; Sten Lund; Ole Schmitz
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

8.  Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity.

Authors:  B Richelsen; S B Pedersen; J D Børglum; T Møller-Pedersen; J Jørgensen; J O Jørgensen
Journal:  Am J Physiol       Date:  1994-02

9.  Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade.

Authors:  Charlotte Nielsen; Lars C Gormsen; Niels Jessen; Steen Bønløkke Pedersen; Niels Møller; Sten Lund; Jens Otto L Jørgensen
Journal:  J Clin Endocrinol Metab       Date:  2008-05-06       Impact factor: 5.958

10.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity.

Authors:  A Dresner; D Laurent; M Marcucci; M E Griffin; S Dufour; G W Cline; L A Slezak; D K Andersen; R S Hundal; D L Rothman; K F Petersen; G I Shulman
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

View more
  8 in total

Review 1.  Mapping the growth hormone--Stat5b--IGF-I transcriptional circuit.

Authors:  Peter Rotwein
Journal:  Trends Endocrinol Metab       Date:  2012-02-21       Impact factor: 12.015

2.  Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner.

Authors:  Manuel D Gahete; José Córdoba-Chacón; Chike V Anadumaka; Qing Lin; Jens C Brüning; C Ronald Kahn; Raúl M Luque; Rhonda D Kineman
Journal:  Endocrinology       Date:  2011-10-11       Impact factor: 4.736

3.  Muscle-specific deletion of signal transducer and activator of transcription 5 augments lipid accumulation in skeletal muscle and liver of mice in response to high-fat diet.

Authors:  Myunggi Baik; Mi Sun Lee; Hyeok Joong Kang; Seung Ju Park; Min Yu Piao; Trang Hoa Nguyen; Lothar Hennighausen
Journal:  Eur J Nutr       Date:  2015-11-18       Impact factor: 5.614

4.  Thyroid hormone and estrogen regulate exercise-induced growth hormone release.

Authors:  Daniele Leão Ignacio; Diego H da S Silvestre; João Paulo Albuquerque Cavalcanti-de-Albuquerque; Ruy Andrade Louzada; Denise P Carvalho; João Pedro Werneck-de-Castro
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

5.  Differential tissue response to growth hormone in mice.

Authors:  Ryan Berry; Graham R McGinnis; Ronadip R Banerjee; Martin E Young; Stuart J Frank
Journal:  FEBS Open Bio       Date:  2018-05-23       Impact factor: 2.693

6.  Association of the Myostatin gene with obesity, abdominal obesity and low lean body mass and in non-diabetic Asian Indians in north India.

Authors:  Surya Prakash Bhatt; Priyanka Nigam; Anoop Misra; Randeep Guleria; Kalpana Luthra; S K Jain; M A Qadar Pasha
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

7.  An overview of the contribution of fatness and fitness factors, and the role of exercise, in the formation of health status for individuals who are overweight.

Authors:  James E Clark
Journal:  J Diabetes Metab Disord       Date:  2012-10-11

8.  Diagnosing sarcopenia: Functional perspectives and a new algorithm from the ISarcoPRM.

Authors:  Murat Kara; Bayram Kaymak; Walter Frontera; Ayşe Merve Ata; Vincenzo Ricci; Timur Ekiz; Ke-Vin Chang; Der-Sheng Han; Xanthi Michail; Michael Quittan; Jae-Young Lim; Jonathan F Bean; Franco Franchignoni; Levent Özçakar
Journal:  J Rehabil Med       Date:  2021-06-21       Impact factor: 2.912

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.